HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maarten Leyssen Selected Research

smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic

1/2022Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the Congo.
1/2022Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial.
1/2022Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial.
1/2021Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maarten Leyssen Research Topics

Disease

9Hepatitis B
12/2014 - 10/2009
5Hepatitis A (Hepatitis, Infectious)
01/2016 - 06/2010
4Vaccinia
01/2022 - 01/2021
3Pain (Aches)
11/2023 - 01/2021
3Ebola Hemorrhagic Fever
01/2022 - 01/2022
2Fever (Fevers)
11/2023 - 01/2022
2Malaria
01/2022 - 01/2022
2Headache (Headaches)
01/2022 - 01/2021
2Diphtheria
12/2014 - 07/2013
2Tetanus
12/2014 - 07/2013
2Whooping Cough (Pertussis)
12/2014 - 07/2013
2Poliomyelitis (Polio)
12/2014 - 07/2013
2Infections
06/2012 - 10/2009
2Renal Insufficiency (Renal Failure)
02/2011 - 07/2010
1COVID-19
01/2022
1Communicable Diseases (Infectious Diseases)
01/2021
1Myalgia
01/2021
1Fatigue
01/2021
1Thrombocytopenia (Thrombopenia)
07/2013
1Intellectual Disability (Idiocy)
06/2013
1Mumps
06/2013
1Measles
06/2013
1Alzheimer Disease (Alzheimer's Disease)
08/2005
1Fragile X Syndrome (Martin Bell Syndrome)
06/2005
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
06/2003

Drug/Important Bio-Agent (IBA)

17VaccinesIBA
01/2022 - 01/2010
4smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordicIBA
01/2022 - 01/2021
3Glycoproteins (Glycoprotein)IBA
01/2022 - 01/2021
3NucleoproteinsIBA
01/2022 - 01/2021
3AntibodiesIBA
06/2012 - 06/2010
2Ebola VaccinesIBA
11/2023 - 01/2022
2AntigensIBA
12/2014 - 12/2010
2Hepatitis A AntibodiesIBA
08/2011 - 06/2010
2Hepatitis B Vaccines (Hepatitis B Vaccine)IBA
02/2011 - 10/2009
1SuspensionsIBA
01/2022
1Combined VaccinesIBA
07/2013
1Ubiquitin-Conjugating EnzymesIBA
06/2013
1Conjugate VaccinesIBA
06/2013
1Rubella VaccineIBA
06/2013
1Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA
06/2013
1Surface Antigens (Surface Antigen)IBA
06/2012
1twinrixIBA
03/2011
1Proteins (Proteins, Gene)FDA Link
08/2005
1Amyloid (Amyloid Fibrils)IBA
08/2005
1Fragile X Mental Retardation ProteinIBA
06/2005
12,3- dioxo- 6- nitro- 7- sulfamoylbenzo(f)quinoxaline (NBQX)IBA
06/2003
1propionic acid (potassium propionate)IBA
06/2003
1AMPA Receptors (AMPA Receptor)IBA
06/2003

Therapy/Procedure

1Injections
01/2021
1Peritoneal Dialysis
02/2011
1Renal Dialysis (Hemodialysis)
02/2011